do compound pharmacies have to stop making tirzepatide FDA says compounding can keep weight-loss med tirzepatide, for now COMPOUNDED TIRZEPATIDE

Deep brain stimulation of the dentate nucleus improves cerebellar ataxia after cerebellar stroke

In research settings, this peptide has shown an ability to trigger arousal responses in animal and early human studies

This landscape illustrates both the promise and challenges: multiple valid targets exist, but translational failures have been common

This underscores the pressing necessity for the development of more innovative therapeutic interventions

We employed the well-established model of Pseudomonas aeruginosa (PA14) infection 41 and found that all three mutants survived better upon PA14 infection compared to WT worms (Supplementary Fig